Advanced Biomedical Technologies Inc Quick Ratio (ABMT) starting from the third quarter 2021 to third quarter 2020, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Advanced Biomedical Technologies Inc   (ABMT)

Advanced Biomedical Technologies Inc 's Quick Ratio

ABMT's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2021, Quick Ratio fell to 0 a new company low.

Within Medical Equipment & Supplies industry 246 other companies have achieved higher Quick Ratio than Advanced Biomedical Technologies Inc in third quarter 2021. While Quick Ratio total ranking has improved so far during the Q3 2021 to 5942, from total ranking in the second quarter 2021 at 5960.

Explain Quick Ratio?
How much Cash & cash equivalents ABMT´s has?
What are ABMT´s Current Liabilities?




ABMT Quick Ratio (Jul 31 2021)
Q3
(Apr 30 2021)
Q2
(Jan 31 2021)
Q1
(Oct 31 2020)
Q4
(Jul 31 2020)
Q3
Y / Y Current Liabilities Change 0.55 % 1.46 % 0.57 % -20.79 % 10.26 %
Y / Y Cash & cash equivalent Change -51.75 % -43.53 % 5.01 % 3506.29 % 33.07 %
Quick Ratio MRQ 0 0 0 0.04 0
ABMT's Total Ranking # 5942 # 5960 # 4899 # 5549 # 5927
Seq. Current Liabilities Change 3.09 % 2.14 % 30.77 % -26.98 % 4.03 %
Seq. Cash & cash equivalent Change 16.23 % -29.24 % -95.79 % 1293.28 % 36.03 %



Quick Ratio third quarter 2021 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 247
Healthcare Sector # 1231
Overall Market # 5942


Quick Ratio Statistics
High Average Low
0.03 0.01 0
(Oct 31 2020)   (Oct 31 2019)




Financial Statements
Advanced Biomedical Technologies Inc 's Current Liabilities $ 7 Millions Visit ABMT's Balance sheet
Advanced Biomedical Technologies Inc 's Cash & cash equivalent $ 0 Millions Visit ABMT's Balance sheet
Source of ABMT's Sales Visit ABMT's Sales by Geography


Cumulative Advanced Biomedical Technologies Inc 's Quick Ratio

ABMT's Quick Ratio for the trailling 12 Months

ABMT Quick Ratio

(Jul 31 2021)
12 Months
(Apr 30 2021)
12 Months
(Jan 31 2021)
12 Months
(Oct 31 2020)
12 Months
(Jul 31 2020)
12 Months
Y / Y Current Liabilities TTM Growth -4.35 % -2.12 % -0.65 % 1.59 % 10.93 %
Y / Y Cash & cash equivalent TTM Growth 475.24 % 555.31 % 545.72 % 418.53 % -16.69 %
Quick Ratio TTM 0.01 0.01 0.01 0.01 0
Total Ranking TTM # 4808 # 4822 # 5136 # 4596 # 4795
Seq. Current Liabilities TTM Growth 0.15 % 0.39 % 0.15 % -5 % 2.49 %
Seq. Cash & cash equivalent TTM Growth -3.25 % -1.97 % 0.17 % 505.44 % 10.22 %


On the trailing twelve months basis In Spite of the rise in Current Liabilities in the Q3 2021 to $7.30 millions, cumulative Quick Ratio remained unchanged at 0.01 below the Advanced Biomedical Technologies Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 217 other companies have achieved higher Quick Ratio than Advanced Biomedical Technologies Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2021 from 4421 to 4891.

Explain Quick Ratio?
How much Cash & cash equivalents ABMT´s has?
What are ABMT´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 218
Healthcare Sector # 1029
Within the Market # 5942


trailing twelve months Quick Ratio Statistics
High Average Low
0.02 0.01 0
  (Apr 30 2020)




Companies with similar Quick Ratio in the quarter ending Jul 31 2021, within Medical Equipment & Supplies Industry Quick RatioJul 31 2021 MRQ Cash & cash equivalentJul 31 2021 MRQ Current Liabilities
Bone Biologics Corporation 0.00 $ 0.004  Millions$ 2.129  Millions
Imaging Diagnostic Systems Inc 0.00 $ 0.002  Millions$ 1.379  Millions
Skinhealth Systems Inc 0.00 $ 0.002  Millions$ 1.129  Millions
Fonar Corporation 0.00 $ 0.032  Millions$ 20.049  Millions
Marizyme Inc 0.00 $ 0.002  Millions$ 1.474  Millions
Advanced Biomedical Technologies Inc 0.00 $ 0.007  Millions$ 7.304  Millions
Regenicin Inc 0.00 $ 0.003  Millions$ 4.850  Millions
Endonovo Therapeutics Inc 0.00 $ 0.009  Millions$ 19.179  Millions

Date modified: 2026-09-08T15:10:22+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.